| Literature DB >> 25107450 |
Beate Pesch1, Anne Lotz, Holger M Koch, Boleslaw Marczynski, Swaantje Casjens, Heiko U Käfferlein, Peter Welge, Martin Lehnert, Evelyn Heinze, Rainer Van Gelder, Jens-Uwe Hahn, Thomas Behrens, Monika Raulf, Andrea Hartwig, Tobias Weiss, Thomas Brüning.
Abstract
The International Agency for Research on Cancer considers the carcinogenicity of welding fume of priority for re-evaluation. Genotoxic effects in experimental animals are still inconclusive. Here, we investigated the association of personal exposure to metals in respirable welding fumes during a working shift with oxidatively damaged guanosine in DNA of white blood cells (WBC) and in postshift urine samples from 238 welders. Medians of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGuo) were 2.35/10(6) dGuo in DNA of WBC and 4.33 µg/g creatinine in urine. The median of 8-oxo-7,8-dihydroguanosine (8-oxoGuo) was 7.03 µg/g creatinine in urine. The extent of both urinary parameters was higher in welders applying techniques with high particle emission rates to stainless steel than in tungsten inert gas welders (8-oxodGuo: 9.96 vs. 4.49 µg/L, 8-oxoGuo: 15.7 vs. 7.7 µg/L), but this apparent difference diminished after creatinine adjustment. We applied random intercept models to estimate the influence of airborne and systemic exposure to metals on oxidatively damaged guanosine in WBC and urine together with covariates. We observed a highly significant nonlinear association of urinary 8-oxoGuo with serum ferritin (P < 0.0001) and higher 8-oxoGuo concentrations for respirable iron >1,000 µg/m(3) compared to ≤57 µg/m(3). Similar effects were found for manganese. Airborne chromium but not nickel was associated with all oxidatively modified guanosine measures, whereas urinary chromium as well as nickel showed associations with urinary modified guanosines. In summary, oxidatively damaged urinary guanosine was associated with airborne and systemic exposure to metals in welders and showed a strong relation to body iron stores.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25107450 PMCID: PMC4508371 DOI: 10.1007/s00204-014-1319-2
Source DB: PubMed Journal: Arch Toxicol ISSN: 0340-5761 Impact factor: 5.153
Fig. 1Association between age and urinary 8-oxo-7,8-dihydro-2′-oxyguanosine in 238 welders
Fig. 2Association between serum ferritin and urinary 8-oxo-7,8-dihydro-2′-oxyguanosine in 238 welders
Distribution of oxidative guanosine adducts and of exposure variables in all welders and in selected exposure circumstances
| Total | High-exposure group: gas metal arc welders with massive or flux-cored wire of stainless steel | Flux-cored arc welding of mild steel | Tungsten inert gas welders | Welders wearing a powered air-purifying respirator | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Median | Interquartile range |
| Median | Interquartile range |
| Median | Interquartile range |
| Median | Interquartile range |
| Median | Interquartile range | |
| Urinary 8-oxoGuo (µg/L) | 238 (0) | 11.1 | (5.9; 16.1) | 12 (0) | 15.7 | (11.0; 21.4) | 30 (0) | 13.8 | (9.8; 17.2) | 65 (0) | 7.7 | (3.9; 12.1) | 27 (0) | 11.5 | (7.7; 15.1) |
| Urinary 8-oxoGuo (µg/g creatinine) | 238 (0) | 7.03 | (5.99; 9.01) | 12 (0) | 6.59 | (6.09; 8.39) | 30 (0) | 7.62 | (5.97; 9.28) | 65 (0) | 6.41 | (6.00; 8.25) | 27 (0) | 6.58 | (5.45; 7.74) |
| Urinary 8-oxodGuo (µg/L) | 238 (0) | 6.19 | (3.48; 9.58) | 12 (0) | 9.96 | (6.08; 13.78) | 30 (0) | 6.02 | (4.61; 8.06) | 65 (0) | 4.49 | (2.46; 7.94) | 27 (0) | 6.85 | (4.43; 9.38) |
| Urinary 8-oxodGuo (µg/g creatinine) | 238 (0) | 4.33 | (3.43; 5.33) | 12 (0) | 4.28 | (3.93; 5.34) | 30 (0) | 3.79 | (2.84; 4.55) | 65 (0) | 4.41 | (3.45; 5.15) | 27 (0) | 3.92 | (3.23; 4.57) |
| 8-oxodGuo/106dGuo in white blood cells | 217 (0) | 2.35 | (1.72; 3.94) | 12 (0) | 5.53 | (4.44; 6.61) | 30 (0) | 4.79 | (3.78; 6.77) | 50 (0) | 1.98 | (1.67; 2.43) | 27 (0) | 1.92 | (1.59; 3.36) |
| Respirable welding fumes (mg/m3) | 236 (88) | 0.94 | (<0.42; 3.38) | 12 (0) | 4.99 | (1.73; 8.04) | 30 (0) | 7.11 | (4.53; 10.50) | 65 (46) | <0.41 | (<0.36; <0.50) | 26 (25) | <0.40 | (<0.36; <0.45) |
| Respirable manganese (µg/m3) | 236 (5) | 61 | (<9; 300) | 12 (0) | 370 | (191; 919) | 30 (0) | 775 | (370; 1100) | 65 (0) | 9 | (4; 22) | 26 (5) | <4 | (<0; 19) |
| Manganese in whole blood (µg/L) | 238 (0) | 10.3 | (8.3; 13.2) | 12 (0) | 12.5 | (11.2; 15.9) | 30 (0) | 13.5 | (10.8; 16.0) | 65 (0) | 8.7 | (7.1; 10.0) | 27 (0) | 10.7 | (8.4; 12.8) |
| Respirable iron (µg/m3) | 236 (23) | 201 | (31; 901) | 12 (0) | 513 | (354; 858) | 30 (0) | 2,050 | (1,100; 3,000) | 65 (19) | 22 | (<11; 67) | 26 (4) | <15 | (<7; 31) |
| Serum iron (µg/dL) | 238 (0) | 91 | (76; 107) | 12 (0) | 86 | (69; 108) | 30 (0) | 92 | (82; 107) | 65 (0) | 90 | (72; 107) | 27 (0) | 94 | (85; 109) |
| Serum ferritin (µg/L) | 238 (0) | 131 | (77; 241) | 12 (0) | 120 | (86; 207) | 30 (0) | 216 | (121; 317) | 65 (0) | 103 | (74; 164) | 27 (0) | 129 | (85; 224) |
| Urinary iron (µg/L) | 238 (10) | 12.5 | (8.7; 18.9) | 12 (0) | 12.4 | (11.1; 15.4) | 30 (0) | 17.9 | (13.2; 28.6) | 65 (5) | 9.4 | (6.8; 14.2) | 27 (0) | 11.4 | (8.5; 13.7) |
| Respirable chromium (µg/m3) | 236 (55) | <3.8 | (<1.8; 18.0) | 12 (0) | 239.0 | (94.5; 373.0) | 30 (11) | <1.2 | (<0.7; <1.6) | 65 (20) | <2.7 | (<1.9; 6.8) | 26 (6) | <3.5 | (<2.0; <5.0) |
| Chromium in erythrocytes (µg/L) | 235 (220) | <1.50 | (<1.50; <1.50) | 12 (4) | 1.95 | (<1.50; 2.37) | 30 (30) | <1.50 | (<1.50; <1.50) | 65 (65) | <1.50 | (<1.50; <1.50) | 25 (25) | <1.50 | (<1.50; <1.50) |
| Urinary chromium (µg/L) | 238 (106) | 1.19 | (<1.00; 3.75) | 12 (0) | 13.53 | (5.21; 53.03) | 30 (21) | <1.00 | (<1.00; 1.03) | 65 (44) | <1.00 | (<1.00; 1.21) | 27 (9) | 1.86 | (<1.00; 4.42) |
| Respirable nickel (µg/m3) | 236 (76) | <3.1 | (<1.5; 16.5) | 12 (0) | 82.5 | (52.5; 110.0) | 30 (14) | <1.7 | (<1.5; <3.1) | 65 (25) | <1.5 | (<1.0; <4.9) | 26 (7) | <4.4 | (<2.0; 7.2) |
| Urinary nickel (µg/L) | 238 (73) | 2.82 | (<1.50; 6.01) | 12 (0) | 7.92 | (5.78; 10.02) | 30 (5) | 2.70 | (1.68; 4.08) | 65 (38) | <1.50 | (<1.50; 3.10) | 27 (9) | 3.55 | (<1.50; 11.19) |
| Urinary creatinine (g/L) | 238 (0) | 1.53 | (0.86; 2.10) | 12 (0) | 2.00 | (1.55; 3.05) | 30 (0) | 1.68 | (1.20; 2.13) | 65 (0) | 1.13 | (0.58; 1.78) | 27 (0) | 1.80 | (1.35; 2.15) |
Influence of respirable iron and chromium and of other potential predictors on 8-oxodGuo and 8-oxoGuo in welders (random intercept models)
| Fixed effects | Urinary 8-oxoGuo (µg/L) | Urinary 8-oxodGuo (µg/L) | 8-oxodGuo/106 dGuo | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Exp (coefficient) | 95 % CI |
| Exp (coefficient) | 95 % CI |
| Exp (coefficient) | 95 % CI |
| |
| Intercept | 1.99 | (1.04–3.81) | 0.039 | 2.27 | (1.14–4.51) | 0.022 | 2.75 | (1.29–5.84) | 0.011 |
|
| |||||||||
| <LOQ ( | 1.01 | (0.82–1.24) | 0.94 | 1.24 | (0.99–1.56) | 0.059 | 0.95 | (0.73–1.23) | 0.69 |
| ≥LOQ and ≤57 µg/m3 ( | 1 | 1 | 1 | ||||||
| 57–252 µg/m3 ( | 1.04 | (0.89–1.20) | 0.64 | 1.04 | (0.89–1.22) | 0.62 | 1.01 | (0.84–1.21) | 0.93 |
| 252–1,055 µg/m3 ( | 1.02 | (0.88–1.18) | 0.82 | 1.00 | (0.85–1.18) | 0.99 | 0.93 | (0.77–1.13) | 0.47 |
| >1,055 µg/m3 ( | 1.17 | (1.01–1.35) | 0.037 | 1.02 | (0.87–1.20) | 0.81 | 0.95 | (0.77–1.17) | 0.61 |
|
| |||||||||
| <LOQ ( | 0.85 | (0.75–0.98) | 0.022 | 0.83 | (0.72–0.96) | 0.012 | 0.83 | (0.71–0.97) | 0.021 |
| ≥LOQ and ≤6.8 µg/m3 ( | 1 | 1 | 1 | ||||||
| >6.8 µg/m3 ( | 1.00 | (0.89–1.13) | 0.99 | 0.98 | (0.86–1.12) | 0.77 | 1.04 | (0.89–1.23) | 0.61 |
| Ln urinary creatinine (g/L) | 2.56 | (2.39–2.73) | <0.0001 | 2.48 | (2.32–2.66) | <0.0001 | |||
| Active smokers ( | 1.08 | (0.99–1.18) | 0.098 | 1.14 | (1.03–1.25) | 0.0081 | 0.96 | (0.88–1.06) | 0.43 |
| Ln age (years) | 1.42 | (1.21–1.67) | <0.0001 | 1.19 | (1.00–1.41) | 0.056 | 1.00 | (0.84–1.20) | 0.97 |
Influence of serum ferritin, urinary chromium, and other potential predictors on urinary 8-oxodGuo and 8-oxoGuo in welders (random intercept models)
| Fixed effects | Urinary 8-oxoGuo (µg/L) | Urinary 8-oxodGuo (µg/L) | 8-oxodGuo/106 dGuo | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Exp (coefficient) | 95 % CI |
| Exp (coefficient) | 95 % CI |
| Exp (coefficient) | 95 % CI |
| |
| Intercept | 4.30 | (2.24–8.26) | 0.0001 | 4.27 | (2.10–8.68) | 0.0003 | 2.66 | (1.19–5.96) | 0.020 |
| Ln serum ferritin (mg/L) | 1.14 | (1.08–1.19) | <0.0001 | 1.11 | (1.06–1.17) | <0.0001 | 1.00 | (0.94–1.05) | 0.87 |
|
| |||||||||
| <LOQ ( | 0.88 | (0.77–1.00) | 0.044 | 0.95 | (0.83–1.09) | 0.49 | 1.07 | (0.91–1.25) | 0.42 |
| ≥LOQ and ≤1.695 µg/L ( | 1 | 1 | 1 | ||||||
| 1.695–2.825 µg/L ( | 1.00 | (0.86–1.17) | 0.99 | 1.08 | (0.92–1.28) | 0.34 | 1.09 | (0.90–1.31) | 0.38 |
| 2.825–7.850 µg/L ( | 1.19 | (1.01–1.39) | 0.039 | 1.21 | (1.01–1.44) | 0.037 | 1.13 | (0.92–1.39) | 0.25 |
| >7.850 µg/L ( | 1.12 | (0.95–1.32) | 0.16 | 1.14 | (0.95–1.36) | 0.16 | 1.15 | (0.93–1.43) | 0.20 |
| Ln urinary creatinine (g/L) | 2.37 | (2.21–2.53) | <0.0001 | 2.32 | (2.16–2.50) | <0.0001 | |||
| Current smokers ( | 1.07 | (0.98–1.16) | 0.13 | 1.14 | (1.04–1.24) | 0.0058 | 0.97 | (0.88–1.07) | 0.55 |
| Ln age (years) | 1.26 | (1.08–1.47) | 0.004 | 1.05 | (0.89–1.24) | 0.58 | 0.97 | (0.81–1.17) | 0.74 |
Influence of respirable iron and nickel and of other potential predictors on 8-oxodGuo and 8-oxoGuo in welders (random intercept models)
| Fixed effects | Urinary 8-oxoGuo (µg/L) | Urinary 8-oxodGuo (µg/L) | 8-oxodGuo/106 dGuo | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Exp (coefficient) | 95 % CI |
| Exp (coefficient) | 95 % CI |
| Exp (coefficient) | 95 % CI |
| |
| Intercept | 1.97 | (1.02–3.78) | 0.044 | 2.29 | (1.14–4.58) | 0.022 | 2.73 | (1.28–5.82) | 0.012 |
|
| |||||||||
| <LOQ ( | 0.93 | (0.76–1.13) | 0.45 | 1.15 | (0.93–1.44) | 0.20 | 0.89 | (0.69–1.16) | 0.40 |
| ≥LOQ and ≤57 µg/m3 ( | 1 | 1 | 1 | ||||||
| 57–252 µg/m3 ( | 1.00 | (0.87–1.16) | 0.98 | 1.01 | (0.87–1.18) | 0.89 | 1.00 | (0.84–1.19) | 1.00 |
| 252–1,055 µg/m3 ( | 0.96 | (0.82–1.12) | 0.56 | 0.95 | (0.80–1.12) | 0.54 | 0.91 | (0.75–1.10) | 0.32 |
| >1,055 µg/m3 ( | 1.14 | (0.98–1.32) | 0.085 | 1.01 | (0.85–1.19) | 0.95 | 0.97 | (0.80–1.19) | 0.78 |
| Nickel (µg/m3) | |||||||||
| <LOQ ( | 0.97 | (0.86–1.09) | 0.59 | 0.92 | (0.81–1.06) | 0.25 | 0.93 | (0.80–1.09) | 0.39 |
| ≥LOQ and ≤8.4 µg/m3 ( | 1 | 1 | 1 | ||||||
| >8.4 µg/m3 ( | 1.08 | (0.95–1.22) | 0.24 | 1.04 | (0.90–1.19) | 0.61 | 1.08 | (0.92–1.27) | 0.33 |
| Ln urinary creatinine (g/L) | 2.57 | (2.41–2.75) | <0.0001 | 2.50 | (2.33–2.68) | <0.0001 | |||
| Active smokers ( | 1.09 | (0.99–1.19) | 0.072 | 1.14 | (1.04–1.26) | 0.0063 | 0.97 | (0.88–1.07) | 0.59 |
| Ln age (years) | 1.42 | (1.20–1.67) | <0.0001 | 1.18 | (0.99–1.40) | 0.068 | 1.00 | (0.83–1.20) | 0.97 |
Influence of serum ferritin, urinary nickel, and other potential predictors on urinary 8-oxodGuo and 8-oxoGuo in welders (random intercept models)
| Fixed effects | Urinary 8-oxoGuo (µg/L) | Urinary 8-oxodGuo (µg/L) | 8-oxodGuo/106 dGuo | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Exp (coefficient) | 95 % CI |
| Exp (coefficient) | 95 % CI |
| Exp (coefficient) | 95 % CI |
| |
| Intercept | 3.56 | (1.85–6.88) | 0.0006 | 3.84 | (1.90–7.77) | 0.0007 | 2.81 | (1.27–6.22) | 0.014 |
| Ln serum ferritin (mg/L) | 1.14 | (1.08–1.19) | <0.0001 | 1.11 | (1.06–1.17) | <0.0001 | 1.00 | (0.94–1.05) | 0.85 |
|
| |||||||||
| <LOQ ( | 0.94 | (0.83–1.06) | 0.31 | 1.02 | (0.89–1.17) | 0.82 | 0.93 | (0.80–1.09) | 0.36 |
| ≥LOQ and ≤2.63 µg/L ( | 1 | 1 | 1 | ||||||
| 2.63–4.12 µg/L ( | 1.04 | (0.90–1.20) | 0.57 | 0.95 | (0.82–1.11) | 0.54 | 1.12 | (0.95–1.31) | 0.18 |
| 4.12–8.04 µg/L ( | 1.15 | (1.00–1.33) | 0.052 | 1.10 | (0.94–1.28) | 0.25 | 0.96 | (0.81–1.14) | 0.65 |
| >8.04 µg/L ( | 1.23 | (1.05–1.44) | 0.012 | 1.24 | (1.03–1.49) | 0.021 | 0.95 | (0.76–1.18) | 0.61 |
| Ln urinary creatinine (g/L) | 2.37 | (2.21–2.54) | <0.0001 | 2.36 | (2.19–2.54) | <0.0001 | |||
| Current smokers ( | 1.06 | (0.98–1.16) | 0.16 | 1.14 | (1.04–1.25) | 0.0039 | 0.96 | (0.87–1.05) | 0.36 |
| Ln age (years) | 1.30 | (1.11–1.52) | 0.0013 | 1.07 | (0.91–1.27) | 0.42 | 0.98 | (0.82–1.18) | 0.86 |